Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation (Tables)

v3.26.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Schedule of Stock Based Compensation Expense

Stock-based compensation expense is as follows (in thousands of dollars):

 

             
    For the Three Months Ended  
    March 31,  
    2026     2025  
Cost of revenues   $ 13     $ 2  
Research and development     20      

2

 
Sales and marketing     60       65  
General and administrative     211      

221

 
Stock-based compensation expenses   $ 304     $ 290  
Schedule of Stock Option Activity

Stock option activity, as adjusted for the Reverse Stock Split, for the three months ended March 31, 2026, is in the table below (price per share is in dollars):

    Options     Weighted
average
exercise
price per
share
    Weighted
average
remaining
contractual
life (in
years)
    Aggregate
Intrinsic
Value*
 
Outstanding at January 1, 2026     34,883     $ 110.67                  
Granted                            
Forfeited     (7,361 )     99.84                  
Expired     (749 )     225.30                  
Outstanding at March 31, 2026     26,773     $ 110.44       6.94     $  
Vested and Expected to Vest at March 31, 2026     26,773     $ 110.44       6.94     $  
Exercisable at March 31, 2026     26,077     $ 110.44       6.91     $  

 

* The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the balance sheet date.
Schedule of Outstanding Restricted Stock Units

Restricted Stock Unit (“RSU”) activity, as adjusted for the Reverse Stock Splits, for the three months ended March 31, 2026, is as follows:

 

    RSUs  
Outstanding at January 1, 2026      
Granted     85,000  
Released      
Forfeited      
Outstanding at March 31, 2026     85,000  
Warrant [Member]  
Schedule of Warrant Activity

Warrants activity, as adjusted for the Reverse Stock Split, for the three months ended March 31, 2026, is as follows:

 

    Number of warrants     Weighted
average
exercise
price per
share
 
Outstanding at January 1, 2026     62,979     $ 13.75  
Granted            
Forfeited            
Expired            
Outstanding at March 31, 2026     62,979     $ 13.75  
Exercisable at March 31, 2026     62,979     $ 13.75